Review
Published on 01 Apr 2022
Molecular Mechanisms Involving the Sonic Hedgehog Pathway in Lung Cancer Therapy: Recent Advances
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.729088
- 6,255 views
- 20 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,969 articles
articles
Original Research
Published on 31 Mar 2022
A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled Trial
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.835582
- 5,140 views
- 16 citations
Review
Published on 31 Mar 2022
BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.863043
- 34,477 views
- 68 citations
Case Report
Published on 31 Mar 2022
Effective Systemic Treatment of Choroidal Metastases NSCLC With Surgery After Crizotinib: A Case Report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.789941
- 4,241 views
- 2 citations
Review
Published on 29 Mar 2022
HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.860313
- 23,910 views
- 37 citations
Case Report
Published on 29 Mar 2022
Case Report: Aumolertinib as Neoadjuvant Therapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer With Activated EGFR Mutation: Case Series
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.872225
- 4,547 views
- 5 citations
Original Research
Published on 28 Mar 2022
Identification of a Prognostic Signature Composed of GPI, IL22RA1, CCT6A and SPOCK1 for Lung Adenocarcinoma Based on Bioinformatic Analysis of lncRNA-Mediated ceRNA Network and Sample Validation
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.844691
- 4,563 views
- 4 citations
Original Research
Published on 28 Mar 2022
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.856132
- 6,114 views
- 5 citations
Original Research
Published on 25 Mar 2022
Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.834761
- 12,028 views
- 32 citations
Original Research
Published on 21 Mar 2022
EGFR Q787Q Polymorphism Is a Germline Variant and a Prognostic Factor for Lung Cancer Treated With TKIs
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.816801
- 3,367 views
- 3 citations
Original Research
Published on 18 Mar 2022
Based on SEER Database: Population Distribution, Survival Analysis, and Prognostic Factors of Organ Metastasis of Lung Large Cell Neuroendocrine Carcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.810170
- 5,210 views
- 7 citations
Review
Published on 17 Mar 2022
NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.864666
- 31,451 views
- 84 citations
Original Research
Published on 17 Mar 2022
Analgesic Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Advanced Non-Small-Cell Lung Cancer: A Randomized, Sham-Controlled, Pilot Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.840855
- 4,450 views
- 18 citations
Original Research
Published on 17 Mar 2022
Comparison of the Detection Rates of Different Diagnostic Methods for Primary Peripheral Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.696239
- 3,700 views
- 6 citations
Correction
Published on 15 Mar 2022
Corrigendum: Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.878864
- 1,866 views
- 2 citations
Original Research
Published on 15 Mar 2022
Drug-Eluting Bead Bronchial Arterial Chemoembolization With and Without Microwave Ablation for the Treatment of Advanced and Standard Treatment-Refractory/Ineligible Non-Small Cell Lung Cancer: A Comparative Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.851830
- 4,474 views
- 24 citations
Original Research
Published on 15 Mar 2022
Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.780631
- 3,304 views
- 9 citations
Review
Published on 15 Mar 2022
Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.859152
- 9,505 views
- 28 citations
Original Research
Published on 10 Mar 2022
Deleterious AHNAK2 Mutation as a Novel Biomarker for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.798401
- 5,584 views
- 10 citations
Original Research
Published on 10 Mar 2022
Fibroblast Activation Protein Specific Optical Imaging in Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.834350
- 6,889 views
- 4 citations
Original Research
Published on 08 Mar 2022
The Effect of Extracellular Superoxide Dismutase (SOD3) Gene in Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.722646
- 5,080 views
- 19 citations
Brief Research Report
Published on 07 Mar 2022
Is There a Role for Large Exome Sequencing in the Management of Metastatic Non-Small Cell Lung Cancer: A Brief Report of Real Life
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.863057
- 2,792 views
- 4 citations
Original Research
Published on 03 Mar 2022
NcRNA-Mediated High Expression of HMMR as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.846536
- 4,609 views
- 16 citations
Correction
Published on 03 Mar 2022
Corrigendum: Construction and Validation of a Lung Cancer Risk Prediction Model for Non-Smokers in China
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.871848
- 1,947 views
- 2 citations